(Q38085061)

28 August 2017

The predictive value of steatosis in hepatitis C virus infection (English)

1 reference

28 August 2017

1 reference

1 reference

1 reference

Luigi E Adinolfi

1

1 reference

PubMed ID

23445230

28 August 2017

Luciano Restivo

series ordinal

2

1 reference

PubMed ID

23445230

28 August 2017

Aldo Marrone

series ordinal

3

1 reference

28 August 2017

1 March 2013

1 reference

Expert Review of Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

7

1 reference

28 August 2017

3

1 reference

28 August 2017

205-213

1 reference

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

28 August 2017

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

21 January 2018

1 reference

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.

21 January 2018

1 reference

Hepatitis C and steatosis: a reappraisal

21 January 2018

1 reference

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

21 January 2018

1 reference

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

21 January 2018

1 reference

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations

21 January 2018

1 reference

Nonalcoholic fatty liver disease: from clinical recognition to treatment

21 January 2018

1 reference

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

21 January 2018

1 reference

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

21 January 2018

1 reference

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

21 January 2018

1 reference

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection

21 January 2018

1 reference

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

Early antipyretic exposure does not increase mortality in patients with gram-negative severe sepsis: a retrospective cohort study.

21 January 2018

1 reference

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

Steatosis and insulin resistance in hepatitis C: a way out for the virus?

21 January 2018

1 reference

The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

21 January 2018

1 reference

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

21 January 2018

1 reference

Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.

21 January 2018

1 reference

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

21 January 2018

1 reference

Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C virus to hepatocellular carcinoma.

21 January 2018

1 reference

Metabolic alterations and chronic hepatitis C: treatment strategies

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.

21 January 2018

1 reference

Hepatitis C and diabetes: the inevitable coincidence?

21 January 2018

1 reference

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus

21 January 2018

1 reference

Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening

21 January 2018

1 reference

Hepatitis C virus RNA localization in human carotid plaques

21 January 2018

1 reference

Does hepatitis C virus infection increase risk for stroke? A population-based cohort study

21 January 2018

1 reference

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 January 2018

1 reference

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

21 January 2018

1 reference

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

21 January 2018

1 reference

Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis?

21 January 2018

1 reference

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

21 January 2018

1 reference

Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR.

21 January 2018

1 reference

Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.

21 January 2018

1 reference

Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture

21 January 2018

1 reference

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.13.7

1 reference

28 August 2017

1 reference

PubMed ID

23445230